SCHEMBL4728916

SCHEMBL4728916

O=C(C=Cc1ccccn1)C12CC3CC(CC(C3)C1)C2

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.59
LMNA P02545 1/20 0.59
HTT P42858 1/20 0.59
RAB9A P51151 3/20 0.50
NPC1 O15118 1/20 0.50
P2RX7 Q99572 1/20 0.50
KDM4E B2RXH2 1/20 0.49
MAPT P10636 1/20 0.49
AGTR1 P30556 1/20 0.49
OPRK1 P41145 1/20 0.49
RECQL P46063 1/20 0.49
GRM5 P41594 2/20 0.47
HSD11B1 P28845 2/20 0.47
HSP90AA1 P07900 1/20 0.46
CYP3A4 P08684 1/20 0.45
CYP2D6 P10635 1/20 0.45
GRM1 Q13255 1/20 0.45
NPSR1 Q6W5P4 1/20 0.45
MEN1 O00255 1/20 0.45
GAA P10253 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8207163 0.83 ALDH1A1 (0.46) ALDH1A1LMNAHTTRAB9ANPC1
SCHEMBL6090139 0.79 NPC1 (0.51) ALDH1A1LMNAHTTRAB9ANPC1
SCHEMBL6091145 0.78 GABBR2 (0.53) ALDH1A1LMNAHTTP2RX7KDM4E
SCHEMBL12040547 0.78 GABBR2 (0.53) ALDH1A1LMNAHTTP2RX7KDM4E
SCHEMBL4727011 0.78 LMNA (0.57) ALDH1A1LMNAHTTRAB9ANPC1
SCHEMBL4726961 0.78 KMT2A (0.43) ALDH1A1LMNAHTTP2RX7KDM4E
SCHEMBL6092082 0.76 ALDH1A1 (0.50) ALDH1A1LMNAHTTRAB9ANPC1
SCHEMBL8068014 0.76 JUN (0.51) ALDH1A1LMNAHTTKDM4EMAPT
SCHEMBL6092331 0.76 JUN (0.51) ALDH1A1LMNAHTTKDM4EMAPT
SCHEMBL3349779 0.76 NPC1 (0.58) ALDH1A1LMNARAB9ANPC1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060074083-A1 Cyclic and acyclic propenones for treating CNS disorders MERZ PHARMA GMBH & CO. KGAA (DE) 2006-04-06 US claimed
WO-2008035049-A1 ADAMANTANYL-(CYCLOPROPYL)-KETONES AS METABOTROPIC GLUTAMATE RECEPTOR MODULATORS MERZ PHARMA GMBH & CO. KGAA (DE) 2008-03-27 WO disclosed
US-20060074083-A1 Cyclic and acyclic propenones for treating CNS disorders MERZ PHARMA GMBH & CO. KGAA (DE) 2006-04-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060074083-A1 Cyclic and acyclic propenones for treating CNS disorders PMP22, ADCYAP1R1, CYP11B2 ALDH1A1 934/4885LMNA 2359/4885HTT 244/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.